Leap Therapeutics, Inc. Gains 368.57%
Wed, Nov 12, 2025 at 07:15 PM
Leap Therapeutics, Inc. (LPTX:NASDAQ) shot up at $2.05, representing a gain of 368.6%. On Wed, Nov 12, 2025, LPTX:NASDAQ hit a New 2-Week High of $2.05. The stock appeared on our News Catalysts scanner on Wed, Nov 12, 2025 at 06:33 PM in the 'HALT' category. From Wed, Oct 29, 2025, the stock recorded 20.00% Up Days and 27.27% Green Days
About Leap Therapeutics, Inc. (LPTX:NASDAQ)
Leap Therapeutics Inc is a biopharmaceutical company . The Company is engaged in acquiring and developing novel therapeutics at the leading edge of cancer biology.
Top 10 Gainers:
- Leap Therapeutics, Inc. (LPTX:NASDAQ), 368.57%
- Spruce Power Holding Corporation (SPRU:NYSE), 54.75%
- FTC Solar, Inc. (FTCI:NASDAQ), 49.8%
- Quhuo Limited (QH:NASDAQ), 48.14%
- Motorsport Games Inc. (MSGM:NASDAQ), 45.67%
- Magnitude International Ltd (MAGH:NASDAQ), 41.61%
- Cambium Networks Corporation (CMBM:NASDAQ), 36%
- Wearable Devices Ltd. (WLDS:NASDAQ), 32.84%
- Intensity Therapeutics, Inc. (INTS:NASDAQ), 31.28%
- MaxsMaking Inc. (MAMK:NASDAQ), 30.31%